Editas Medicine, Inc. (EDIT) Presents at Wells Fargo 2024 Healthcare Conference (Transcript) [Seeking Alpha]
Editas Medicine, Inc. (EDIT)
Last editas medicine, inc. earnings: 2/26 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.editasmedicine.com
Company Research
Source: Seeking Alpha
Follow Editas Medicine, Inc. ( NASDAQ: EDIT ) Wells Fargo 2024 Healthcare Conference September 5, 2024 4:30 PM ET Company Participants Gilmore O'Neill - CEO Erick Lucera - CFO Conference Call Participants Yanan Zhu - Wells Fargo Securities Yanan Zhu Let's get started. Thanks, everyone, for being here. My name is Yanan Zhu and I'm one of the Biotech analyst here at Wells Fargo. It is my great pleasure to introduce our next company for the fireside session, Editas Medicine. Here with me are the management team, Gilmore O'Neill, Chief Executive Officer; and Erick Lucera, Chief Financial Officer. Thank you for being with us. Gilmore O'Neill Good to be here. Thank you. Erick Lucera Great to be here. Yanan Zhu Great. I was wondering if you can give a brief overview of the company's platform and program. A - Gilmore O'Neill Yes, happy to do that and thanks again, Yanan, to you and to Wells Fargo for this opportunity. Editas is a CRISPR-based genome editing co
Show less
Read more
Impact Snapshot
Event Time:
EDIT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDIT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDIT alerts
High impacting Editas Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
EDIT
News
- Editas Medicine, Inc. (NASDAQ: EDIT) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock.MarketBeat
- Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
- Editas Medicine, Inc. (EDIT) Presents at Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) [Seeking Alpha]Seeking Alpha
- Editas Medicine to Participate in Upcoming Investor ConferencesGlobeNewswire
- We're Keeping An Eye On Editas Medicine's (NASDAQ:EDIT) Cash Burn Rate [Yahoo! Finance]Yahoo! Finance
EDIT
Earnings
- 8/7/24 - Miss
EDIT
Sec Filings
- 9/6/24 - Form 4
- 9/6/24 - Form 4
- 8/29/24 - Form 144
- EDIT's page on the SEC website